Sinus; Inflammation Clinical Trial
Official title:
A User Study of SYNUS Pain Relief Made by Tivic Health Systems
NCT number | NCT03466879 |
Other study ID # | CP00001 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | February 2, 2018 |
Est. completion date | July 21, 2018 |
Verified date | December 2018 |
Source | Tivic Health Systems |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Demonstrate the ability of subjects suffering from sinus pain to self-treat with the SYNUS Pain Relief device and to obtain pain relief compared to a sham/placebo device.
Status | Completed |
Enrollment | 72 |
Est. completion date | July 21, 2018 |
Est. primary completion date | July 21, 2018 |
Accepts healthy volunteers | |
Gender | All |
Age group | 18 Years to 99 Years |
Eligibility |
Inclusion Criteria: - Be 18 years of age and older - Present with symptoms of sinus pain and pressure - Have an initial sinus pain score of 4 or more on the visual analogue scale - Be able to read and understand English - Agree to participate in the study - Be able and willing to provide Informed Consent Exclusion Criteria: - Do not meet Inclusion Criteria - Have currently a dental infection - Have currently abnormal cranial nerve or other neurological findings or symptoms that would require prompt medical attention - Be currently pregnant - Have implanted electrostimulation devices including a pacemaker, a DBS or a cochlear implant |
Country | Name | City | State |
---|---|---|---|
United States | Stanford University | Stanford | California |
Lead Sponsor | Collaborator |
---|---|
Tivic Health Systems | Stanford University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Pain reduction | Average decrease in pain score of the SYNUS device is greater than the average decrease is pain score for the sham/placebo device. | 10 minutes |